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Background
Hematopoietic stem cell (HSC) transplantation is the only
treatment providing long-term cure in acute myeloblastic
leukemia. At the apex of the hematopoietic system, quies-
cent HSCs escape to chemotherapeutic treatments and
therefore can regenerate the entire blood system after
drug exposure. Nevertheless, the consequence of repeated
chemotherapy regimen on HSC function remains to be
clarified. In this study, we investigate how massive expan-
sion in vivo influence HSC functions.
Methods and results
We optimized a protocol based on 5-fluorouracil (5FU),
an antimetabolite used to treat different types of cancers.
We show that after one 5FU treatment, HSCs exit quies-
cence and enter the cell cycle. To deplete cycling HSCs,
we injected a second dose of 5FU and show that the stem
cell pool is disseminated. Nonetheless, the remaining
HSCs proliferate extensively to re-establish the HSC pool.
At this point, most HSCs have exited the cell cycle and are
back to quiescence. Despite a near normal stem cell pool
size and a quiescent status, HSCs from these 5FU treated
mice cannot compete against untreated cells to regenerate
the host in transplantation assays. Furthermore, we show
that this extensive proliferation in vivo severely impairs
the clonal expansion of individual HSC as measured by
the mean activity of stem cell (MAS).
Conclusion
Our results demonstrate that HSCs loose their competitive
potential after two 5FU treatments, suggesting that HSCs
have an intrinsic expansion limit beyond which their
regenerative potential is impaired. We surmise that che-
motherapy regimens based on repeated administration of
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